Common mutations present in both tumour and plasma samples were predominantly in TP53 and PIK3CA (Supplementary Table 6); however, one ESR1 mutation (p.D538G, 70.8% VAF) was also detected in the baseline plasma sample matched to one patient (P5, 0.75% VAF). Here, ESR1 is linked to neoplasm.